{"id":"W3096690841","doi":"10.1182/blood-2020-139182","title":"Dreamm-5 Platform Trial: Belantamab Mafodotin (Belamaf) in Combination with Four Different Novel Agents in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interim analysis; Multiple myeloma; Lenalidomide; Pomalidomide; Oncology; Dosing; Pharmacology; Refractory (planetary science); Cmax; Internal medicine; Adverse effect; Pharmacokinetics; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001742069,0.001062581,0.001355217,0.0003367922,0.0002640779,0.001026915,0.0008233755,0.0007108732,0.003151727],"category_scores_gemma":[0.0007104899,0.0003545195,0.001302633,0.0002704727,0.0006450154,0.0008803298,0.0006197288,0.001954861,0.0006625039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00126918,"about_ca_system_score_gemma":0.001390494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008111058,"about_ca_topic_score_gemma":0.002520491,"domain_scores_codex":[0.9995029,0.0002201897,0.0000314315,0.0001022013,0.00006423464,0.00007904214],"domain_scores_gemma":[0.9996874,0.00004397003,0.00007623875,0.0000335128,0.0000200849,0.0001386584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8056934,0.01440421,0.004660563,0.001505648,0.002146832,0.0001331853,0.0002629305,0.002996214,0.02201222,0.0008916786,0.005271637,0.1400215],"study_design_scores_gemma":[0.6617843,0.3126125,0.009603852,0.000106256,0.0008703196,0.0003202663,0.00006608054,0.001424699,0.004199029,0.0003892071,0.008578544,0.00004500804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853606,0.005513851,0.0006447614,0.0006730612,0.0001993412,0.001948963,0.001595599,0.0001558899,0.003907896],"genre_scores_gemma":[0.9881396,0.00160361,0.002006346,0.0007036385,0.0001711925,0.001600079,0.002562893,0.0000223611,0.003190211],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003151727,"threshold_uncertainty_score":0.01054353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04663736924831915,"score_gpt":0.2639642465014611,"score_spread":0.217326877253142,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}